Vagistat-3
Pricing Report NDC 0067-2091-03
View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Current Package Pricing Information
This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.
The latest wholesale acquisition cost for Vagistat-3 (NDC 0067-2091-03) is $8.14000 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 17, 2017.
As a provided by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this medication is distributed in a 1 KIT in 1 CARTON * 3 SUPPOSITORY in 1 BLISTER PACK * 1 TUBE in 1 CARTON / 9 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $8.14000 Per EA
Pricing Unit
Effective Date
May 17, 2017
Data Status
As of May 16, 2018
Generic Benchmark
The generic equivalent rate is
$7.58545
(Effective:
Apr 18, 2018)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $7.85125 to $9.20170 per EA. Over this 3 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
Price Range
$7.8513 - $9.2017
$7.8513 - $9.2017
Market Volatility
17.20% Variance
17.20% Variance
Latest Trend
5.55%
5.55%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 17, 2017 | $8.14000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 21, 2016 | $8.61800 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 21, 2016 | $8.61800 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 21, 2016 | $8.61800 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 21, 2016 | $8.61800 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 21, 2016 | $8.61800 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 23, 2016 | $9.20170 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 01, 2016 | $8.50923 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 20, 2016 | $8.18400 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 20, 2016 | $8.18400 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 20, 2016 | $8.18400 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 20, 2016 | $8.18400 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 23, 2015 | $8.04333 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 22, 2015 | $7.85125 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 22, 2015 | $7.85125 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 20, 2015 | $8.11400 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| May 20, 2015 | $8.11400 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 22, 2015 | $7.99400 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B - Brand |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2014 | $8.07000 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 21, 2013 | $7.94200 | EA | C/I - Chain or Independent Pharmacy | Code 1 | G - Generic |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
